Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor-Reference-Cited by-同舟云学术

Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor

Published:2015-07-01 Issue:3 Volume:88 Page:502-511
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Chang Steven D.^ORCID,Mascarella S. Wayne^ORCID,Spangler Skylar M.,Gurevich Vsevolod V.^ORCID,Navarro Hernan A.,Carroll F. Ivy^ORCID,Bruchas Michael R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. THE BRET2/ARRESTIN ASSAY IN STABLE RECOMBINANT CELLS: A PLATFORM TO SCREEN FOR COMPOUNDS THAT INTERACT WITH G PROTEIN-COUPLED RECEPTORS (GPCRS)*

2. Operational models of pharmacological agonism

3. Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor;Bock;Nat Chem Biol,2014

4. Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery

5. Conformational changes in the G protein Gs induced by the β2 adrenergic receptor

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detecting and measuring of GPCR signaling – comparison of human induced pluripotent stem cells and immortal cell lines;Frontiers in Endocrinology;2023-05-24

2. Biased Agonism: Lessons from Studies of Opioid Receptor Agonists;Annual Review of Pharmacology and Toxicology;2023-01-20

3. Differential In vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G-protein and Beta-arrestin Signaling at the Human Nociceptin Opioid Receptor;Molecular Pharmacology;2021-05-06

4. Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists;Frontiers in Neuroscience;2021-03-30

5. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors;RSC Medicinal Chemistry;2021